1,140 results match your criteria: "Barretos Cancer Hospital[Affiliation]"
Eur J Cancer
November 2024
Princess Máxima Center, Utrecht, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Princess Máxima Center, Utrecht, Netherlands; Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig Maximilians University, Munich, Germany.
Background: Data on the efficacy and safety of anti PD-1 antibodies in children and adolescents (CA) with melanoma are lacking. The aim of this study was to determine outcomes of CA melanoma patients receiving anti PD-1 antibodies.
Methods: Melanoma patients ≤18 years treated with anti PD-1 were retrospectively retrieved from 15 academic centers.
J Neurooncol
December 2024
Department of Neurosurgery, Lenox Hill Hospital/Northwell Health, New York, NY, USA.
Background: High-grade gliomas (HGG) are the most aggressive primary brain tumors with poor prognoses despite conventional treatments. Immunotherapy has emerged as a promising avenue due to its potential to elicit a targeted immune response against tumor cells.
Objective: This meta-analysis aimed to evaluate the efficacy and safety of various immunotherapeutic strategies, including immune checkpoint inhibitors (ICI), virotherapy, and dendritic cell vaccines (DCV) in treating HGG.
JCO Glob Oncol
August 2024
Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN.
Endoscopy
January 2025
Endoscopy Unit, University of Sao Paulo Institute of Cancer of Sao Paulo State, São Paulo, Brazil.
Metabolites
July 2024
Laboratory of Biological Chemistry, Institute of Chemistry, Universidade Estadual de Campinas, Campinas 13083-970, Brazil.
Cancer is a complex disease that can also affect the younger population; however, it is responsible for a relatively high mortality rate of children and youth, especially in low- and middle-income countries (LMICs). Besides that, lipidomic studies in this age range are scarce. Therefore, we analyzed blood serum samples from young patients (12 to 35 years) with bone sarcoma (osteosarcoma) and compared their lipidomics to the ones from the control group of samples, named healthy control (HC group), using NMR and LC-MS techniques.
View Article and Find Full Text PDFAnal Bioanal Chem
November 2024
Chromatography Group, São Carlos Institute of Chemistry, University of São Paulo, São Carlos, São Paulo, Brazil.
Nurs Rep
August 2024
Faculty of Medicine of São José do Rio Preto, São José do Rio Preto 15090-000, Brazil.
Int J Surg
November 2024
Department of Gynecologic Oncology.
Diagn Microbiol Infect Dis
November 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, 1331, Antenor Duarte Vilela St, Barretos, SP, 14784-400, Brazil; National Cancer Institute, 37, André Cavalcanti St, Rio de Janeiro, RJ, 20231-050, Brazil. Electronic address:
Ophthalmic Plast Reconstr Surg
August 2024
Ocular Oncology and Visual Rehabilitation Service, Department of Ophthalmology, Barretos Cancer Hospital, Barretos.
Cancer Control
August 2024
Nutrition and Molecular Biology Research Group, School of Medicine, Federal University of Uberlandia, Uberlandia, Brazil.
Introduction: Neoadjuvant endocrine therapy (NET) is recommended for the treatment of invasive breast cancer (BC), particularly luminal subtypes, in locally advanced stages. Previous randomized studies have demonstrated the benefits of aromatase inhibitors in this context. However, NET is typically reserved for elderly or frail patients who may not tolerate neoadjuvant chemotherapy.
View Article and Find Full Text PDFCan J Ophthalmol
August 2024
Ocular Oncology and Visual Rehabilitation Service, Department of Ophthalmology, Barretos Cancer Hospital, Barretos, SP, Brazil.. Electronic address:
Ophthalmic rehabilitation refers to the multidisciplinary approach to restoring, maximizing, and preserving the visual function and quality of life for patients affected by ocular manifestations of cancer or its treatments. Besides its approach to low vision, ophthalmic rehabilitation also encompasses a series of reconstructive interventions to mitigate anatomic deficits that may interplay with visual impairment. A gamut of oncologic conditions may result in ocular disabilities, including primary intraocular tumours, secondary metastases, or adverse effects of systemic therapies such as chemotherapy, radiation, and surgery.
View Article and Find Full Text PDFJ Clin Neurosci
October 2024
Neurosurgical Oncology Division, Barretos Cancer Hospital, Barretos, SP, Brazil.
Background: Von Hippel-Lindau (VHL) disease is a rare autosomal dominant disorder that predisposes patients to develop multiple cysts and tumors, such as hemangioblastomas (HBs) and clear cell renal cell carcinoma (ccRCC), due to mutations in the VHL tumor suppressor gene. While treatment of HBs varies based on their characteristics and has improved patient survival, it still involves high morbidity and mortality, leading to ongoing debates and studies to refine therapy strategies. Recent developments include the emergence of Belzutifan, a novel inhibitor targeting hypoxia-inducible factor 2α (HIF-2α), which has shown promising results in ongoing trials, particularly for patients not immediately requiring surgery.
View Article and Find Full Text PDFPLoS One
August 2024
Molecular Oncology Research Centre, Barretos Cancer Hospital, Barretos, Brazil.
Heliyon
July 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, 14784-400, Brazil.
Background: Extracellular vesicles (EVs), ubiquitously released by blood cells, facilitate intercellular communication. In cancer, tumor-derived EVs profoundly affect the microenvironment, promoting tumor progression and raising the risk of recurrence. These EVs contain miRNAs (EV-miRNAs), promising cancer biomarkers.
View Article and Find Full Text PDFJ Transl Med
August 2024
Department of Clinical Genetics, University Hospital of Southern Denmark, Beriderbakken 4, Vejle, DK, 7100, Denmark.
Background: Although the clinical signs of inflammatory breast cancer (IBC) resemble acute inflammation, the role played by infiltrating immune and stromal cells in this aggressive disease is uncharted. The tumor microenvironment (TME) presents molecular alterations, such as epimutations, prior to morphological abnormalities. These changes affect the distribution and the intricate communication between the TME components related to cancer prognosis and therapy response.
View Article and Find Full Text PDFJ Neurooncol
September 2024
Department of Neurosurgery, Lenox Hill Hospital/Northwell Health, New York, NY, USA.
Purpose: Recent studies have investigated if the sodium fluorescein-guided (SFg) improves the extent of resection of BMs when compared to standard white light (sWL). Therefore, we aimed to assess the comparative efficacy and safety of SFg and sWL for resection of BMs.
Methods: We searched Medline, Embase, and Cochrane Library databases following Cochrane and PRISMA guidelines for studies reporting comparative data of SFg and WL resection of BMs.
Sci Rep
July 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Germline TP53 pathogenic variants can lead to a cancer susceptibility syndrome known as Li-Fraumeni (LFS). Variants affecting its activity can drive tumorigenesis altering p53 pathways and their identification is crucial for assessing individual risk. This study explored the functional impact of TP53 missense variants on its transcription factor activity.
View Article and Find Full Text PDFCells
July 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, 14784 400 Barretos, Brazil.
[...
View Article and Find Full Text PDFEur J Gastroenterol Hepatol
September 2024
Department of Gastroenterology and Gastrointestinal Endoscopy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Ustekinumab and vedolizumab are key treatment options for Crohn's disease patients who fail anti-tumor necrosis factor (TNF) therapy. This updated meta-analysis aims to compare the efficacy and safety of these two drugs. We performed a systematic review in PubMed, Embase , and Cochrane databases searching for randomized and nonrandomized studies comparing vedolizumab versus ustekinumab in patients with Crohn's disease with previous anti-TNF failure or intolerance.
View Article and Find Full Text PDFClin Epigenetics
July 2024
Department of Clinical Genetics, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.
Background: Inflammatory breast cancer (IBC) is a rare disease characterized by rapid progression, early metastasis, and a high mortality rate.
Methods: Genome-wide DNA methylation analysis (EPIC BeadChip platform, Illumina) and somatic gene variants (105 cancer-related genes) were performed in 24 IBCs selected from a cohort of 140 cases.
Results: We identified 46,908 DMPs (differentially methylated positions) (66% hypomethylated); CpG islands were predominantly hypermethylated (39.
Cancer Prev Res (Phila)
October 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.
Fecal immunochemical test (FIT) followed by colonoscopy in positive cases is commonly used for population-based colorectal cancer screening. However, specificity of FIT for colorectal cancer is not ideal and has poor performance for advanced adenoma detection. Fecal Fusobacterium nucleatum (Fn) detection has been proposed as a potential noninvasive biomarker for colorectal cancer and advanced adenoma detection.
View Article and Find Full Text PDFOncologist
October 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
J Clin Neurosci
August 2024
Department of Neurological Surgery, University of Miami Hospital, Miami, FL, USA.
Background: Traditionally, patients undergoing craniotomy were subject to extended hospital stays for intensive monitoring and management of potential complications. However, with the evolution of surgical methods, anesthesia, and postoperative protocols, the feasibility and interest in same-day discharge (SDD) are growing. This study aimed to evaluate whether same-day discharge is a safe and feasible approach in craniotomy through a meta-analysis of the available literature.
View Article and Find Full Text PDFFront Public Health
June 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.
Introduction: Pollution has emerged as a significant threat to humanity, necessitating a thorough evaluation of its impacts. As a result, various methods for human biomonitoring have been proposed as vital tools for assessing, managing, and mitigating exposure risks. Among these methods, urine stands out as the most commonly analyzed biological sample and the primary matrix for biomonitoring studies.
View Article and Find Full Text PDF